ADAMTS13: The von Willebrand factor cleaving protease and its role in thrombotic thrombocytopenic purpura

Surbhi Saini, Tal Schiller, Andrew Wu, Chava Kimchi-Sarfaty

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Since the discovery of ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) in the twentieth century, signifi - cant advancements have been made in understanding its role in hemostasis, molecular structure, genetics and genotype-phenotype relationships. It is a member of the ADAMTS family of matrix proteases and is responsible for the cleavage of ultralarge molecules of von Willebrand factor (VWF), thus regulating the adhesion of platelets to VWF multimers. Structurally, it resembles other members of the ADAMTS family with the exception of the number of thrombospondin-1 repeats and the presence of two CUB domains at the carboxyl terminal. The proteolytic activity of ADAMTS13 is mediated via an adamalysin-like metalloprotease domain. The ADAMTS13 gene was cloned in 2001 and since then a number of diseasecausing mutations have been discovered across the entirety of this gene. Additionally, ten different splicing isoforms have been described for ADAMTS13 gene and a signifi cant amount of genetic variations in this gene arises from the 1000 genome project (single nucleotide polymorphisms (SNPs)). Phylogenetic origins of ADAMTS13 are also discussed. Defi ciency of this necessary protease activity due to autosomal recessive mutations of the ADAMTS13 gene are implicated in congenital thrombotic thrombocytopenic purpura, also called Upshaw-Schulman syndrome. Ongoing research focuses on the role of ADAMTS13 in other forms of thrombotic microangiopathy and the development of either a plasma-derived or recombinant form of ADAMTS13 for therapeutic purposes.

Original languageEnglish (US)
Title of host publicationProteases in Health and Disease
PublisherSpringer New York
Pages257-276
Number of pages20
ISBN (Electronic)9781461492337
ISBN (Print)9781461492320
DOIs
StatePublished - Jan 1 2013

Fingerprint

Thrombotic Thrombocytopenic Purpura
von Willebrand Factor
Peptide Hydrolases
Genes
Thrombospondin 1
Metalloproteases
Thrombotic Microangiopathies
Disintegrins
Mutation
Molecular Structure
Hemostasis
Single Nucleotide Polymorphism
Molecular Biology
Platelets
Polymorphism
Protein Isoforms
Blood Platelets
Molecular structure
Genotype
ADAMTS13 Protein

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Saini, S., Schiller, T., Wu, A., & Kimchi-Sarfaty, C. (2013). ADAMTS13: The von Willebrand factor cleaving protease and its role in thrombotic thrombocytopenic purpura. In Proteases in Health and Disease (pp. 257-276). Springer New York. https://doi.org/10.1007/978-1-4614-9233-7_15
Saini, Surbhi ; Schiller, Tal ; Wu, Andrew ; Kimchi-Sarfaty, Chava. / ADAMTS13 : The von Willebrand factor cleaving protease and its role in thrombotic thrombocytopenic purpura. Proteases in Health and Disease. Springer New York, 2013. pp. 257-276
@inbook{6dd1e0aca85541ac9808fbfa7feb969f,
title = "ADAMTS13: The von Willebrand factor cleaving protease and its role in thrombotic thrombocytopenic purpura",
abstract = "Since the discovery of ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) in the twentieth century, signifi - cant advancements have been made in understanding its role in hemostasis, molecular structure, genetics and genotype-phenotype relationships. It is a member of the ADAMTS family of matrix proteases and is responsible for the cleavage of ultralarge molecules of von Willebrand factor (VWF), thus regulating the adhesion of platelets to VWF multimers. Structurally, it resembles other members of the ADAMTS family with the exception of the number of thrombospondin-1 repeats and the presence of two CUB domains at the carboxyl terminal. The proteolytic activity of ADAMTS13 is mediated via an adamalysin-like metalloprotease domain. The ADAMTS13 gene was cloned in 2001 and since then a number of diseasecausing mutations have been discovered across the entirety of this gene. Additionally, ten different splicing isoforms have been described for ADAMTS13 gene and a signifi cant amount of genetic variations in this gene arises from the 1000 genome project (single nucleotide polymorphisms (SNPs)). Phylogenetic origins of ADAMTS13 are also discussed. Defi ciency of this necessary protease activity due to autosomal recessive mutations of the ADAMTS13 gene are implicated in congenital thrombotic thrombocytopenic purpura, also called Upshaw-Schulman syndrome. Ongoing research focuses on the role of ADAMTS13 in other forms of thrombotic microangiopathy and the development of either a plasma-derived or recombinant form of ADAMTS13 for therapeutic purposes.",
author = "Surbhi Saini and Tal Schiller and Andrew Wu and Chava Kimchi-Sarfaty",
year = "2013",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-9233-7_15",
language = "English (US)",
isbn = "9781461492320",
pages = "257--276",
booktitle = "Proteases in Health and Disease",
publisher = "Springer New York",
address = "United States",

}

Saini, S, Schiller, T, Wu, A & Kimchi-Sarfaty, C 2013, ADAMTS13: The von Willebrand factor cleaving protease and its role in thrombotic thrombocytopenic purpura. in Proteases in Health and Disease. Springer New York, pp. 257-276. https://doi.org/10.1007/978-1-4614-9233-7_15

ADAMTS13 : The von Willebrand factor cleaving protease and its role in thrombotic thrombocytopenic purpura. / Saini, Surbhi; Schiller, Tal; Wu, Andrew; Kimchi-Sarfaty, Chava.

Proteases in Health and Disease. Springer New York, 2013. p. 257-276.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - ADAMTS13

T2 - The von Willebrand factor cleaving protease and its role in thrombotic thrombocytopenic purpura

AU - Saini, Surbhi

AU - Schiller, Tal

AU - Wu, Andrew

AU - Kimchi-Sarfaty, Chava

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Since the discovery of ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) in the twentieth century, signifi - cant advancements have been made in understanding its role in hemostasis, molecular structure, genetics and genotype-phenotype relationships. It is a member of the ADAMTS family of matrix proteases and is responsible for the cleavage of ultralarge molecules of von Willebrand factor (VWF), thus regulating the adhesion of platelets to VWF multimers. Structurally, it resembles other members of the ADAMTS family with the exception of the number of thrombospondin-1 repeats and the presence of two CUB domains at the carboxyl terminal. The proteolytic activity of ADAMTS13 is mediated via an adamalysin-like metalloprotease domain. The ADAMTS13 gene was cloned in 2001 and since then a number of diseasecausing mutations have been discovered across the entirety of this gene. Additionally, ten different splicing isoforms have been described for ADAMTS13 gene and a signifi cant amount of genetic variations in this gene arises from the 1000 genome project (single nucleotide polymorphisms (SNPs)). Phylogenetic origins of ADAMTS13 are also discussed. Defi ciency of this necessary protease activity due to autosomal recessive mutations of the ADAMTS13 gene are implicated in congenital thrombotic thrombocytopenic purpura, also called Upshaw-Schulman syndrome. Ongoing research focuses on the role of ADAMTS13 in other forms of thrombotic microangiopathy and the development of either a plasma-derived or recombinant form of ADAMTS13 for therapeutic purposes.

AB - Since the discovery of ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) in the twentieth century, signifi - cant advancements have been made in understanding its role in hemostasis, molecular structure, genetics and genotype-phenotype relationships. It is a member of the ADAMTS family of matrix proteases and is responsible for the cleavage of ultralarge molecules of von Willebrand factor (VWF), thus regulating the adhesion of platelets to VWF multimers. Structurally, it resembles other members of the ADAMTS family with the exception of the number of thrombospondin-1 repeats and the presence of two CUB domains at the carboxyl terminal. The proteolytic activity of ADAMTS13 is mediated via an adamalysin-like metalloprotease domain. The ADAMTS13 gene was cloned in 2001 and since then a number of diseasecausing mutations have been discovered across the entirety of this gene. Additionally, ten different splicing isoforms have been described for ADAMTS13 gene and a signifi cant amount of genetic variations in this gene arises from the 1000 genome project (single nucleotide polymorphisms (SNPs)). Phylogenetic origins of ADAMTS13 are also discussed. Defi ciency of this necessary protease activity due to autosomal recessive mutations of the ADAMTS13 gene are implicated in congenital thrombotic thrombocytopenic purpura, also called Upshaw-Schulman syndrome. Ongoing research focuses on the role of ADAMTS13 in other forms of thrombotic microangiopathy and the development of either a plasma-derived or recombinant form of ADAMTS13 for therapeutic purposes.

UR - http://www.scopus.com/inward/record.url?scp=85028502533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028502533&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-9233-7_15

DO - 10.1007/978-1-4614-9233-7_15

M3 - Chapter

AN - SCOPUS:85028502533

SN - 9781461492320

SP - 257

EP - 276

BT - Proteases in Health and Disease

PB - Springer New York

ER -

Saini S, Schiller T, Wu A, Kimchi-Sarfaty C. ADAMTS13: The von Willebrand factor cleaving protease and its role in thrombotic thrombocytopenic purpura. In Proteases in Health and Disease. Springer New York. 2013. p. 257-276 https://doi.org/10.1007/978-1-4614-9233-7_15